AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Eastman Chemical Plunges 11.87% on Earnings Miss
Generated by AI AgentAinvest Pre-Market Radar
Friday, Aug 1, 2025 7:06 am ET1min read
Aime SummaryOn August 1, 2025, Eastman Chemical's stock price plummeted by 11.87% in pre-market trading, signaling a significant downturn for the chemical giant.
Eastman Chemical reported a decline in its second-quarter earnings, with profits dropping to $140 million from $230 million in the same period last year. The company's earnings per share (EPS) also decreased to $1.20 from $1.94, reflecting a 38% year-over-year decline. This earnings miss was attributed to global trade challenges and other non-recurring costs.
Revenue for the quarter was $2.287 billion, down from $2.363 billion in the previous year, indicating a slight decrease in overall sales. The company's earnings and revenue surprises for the quarter were -6.98% and -0.13%, respectively, which further contributed to the stock's decline.
Analysts have noted that the company's performance was impacted by various factors, including global trade challenges and asset impairment costs. Despite these setbacks,
remains focused on its strategic initiatives and long-term growth prospects.
Ainvest Pre-Market Radar
Get the scoop on pre-market movers and shakers in the US stock market.
Latest Articles
Getty Images (NYSE:GETY) surges 5.51% on renewed investor confidence
Jan.02 2026
Olaplex Holdings (NASDAQ: OLPX) shares plunged 7.59% on mixed analyst outlooks and shifting institutional positioning.
Jan.02 2026
The Real Brokerage shares surge 7.04% on Jan. 2 2026 driven by regulatory tailwinds and restructuring optimism
Jan.02 2026
Vanda Pharmaceuticals shares surged 25.46% on partnership and FDA Breakthrough Therapy Designation.
Jan.02 2026
Vanda Pharmaceuticals shares surge 25.46% on partnership and FDA breakthrough designation
Jan.02 2026
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc's editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet